AC Immune boldly prices Nasdaq IPO14.09.2016 – The summer slump on the stock markets is over: AC Immune has confidently priced its long-awaited Nasdaq IPO. The Swiss Alzheimers specialist is expecting to raise up to US$68m (€60.5m) … more ➔
Sanofi, Google launch diabetes venture13.09.2016 – Diabetes major Sanofi is joining forces with Verily – formerly Google Life Sciences – to launch Onduo. The joint venture will develop a comprehensive diabetes management platform. more ➔
Fresh French fund for healthcare09.09.2016 – iBionexts healthcare VC fund iBionext Growth has announced a first closing of €46m. All in all, iBionext aims to take in around €100m to reinvest in biotech and medtech companies. … more ➔
Bed and board go bio-based07.09.2016 – Furniture giant Ikea and renewables expert Neste have joined forces to deliver bio-based plastics based on Neste’s bio-based polymer. The partners urge other companies to join the initiative. more ➔
Boosting vaccines without the prick06.09.2016 – DBVs needle-free patch technology is being put to the test in a a proof of concept trial for a pertussis vaccine developed by BioNet-Asia. Researchers from the Geneva University Hospital … more ➔
Biomarker lifts a secret of old age05.09.2016 – Why do people grow old? Italian researchers took a close look at centenarians and found that low levels of the peptide hormone Adrenomedullin may significantly contribute towards good microcirculation … more ➔
mAb ray of hope for Alzheimers01.09.2016 – The causes of Alzheimer’s disease are still largely unknown. But now, an antibody developed by the University of Zurich has significantly reduced the brain amyloid plaques typical for Alzheimers … more ➔
Ferring bags slipped disk pain drug30.08.2016 – Swiss biopharma company Ferring has acquired the exclusive development and commercialisation rights to Seikagakus Phase III chemonucleolytic leg pain treatment for €85m. more ➔
Phase III washout for AdociaAdocia said it would discontinue its diabetic foot ulcer programme after its lead product BioChaperone PDGF disappointed in Phase III. The French company will turn the focus on its earlier-stage products. more ➔
AZ unloads antibiotics to Pfizer24.08.2016 – Pharma major Pfizer is putting the cherry on top of its multi-billion-dollar takeover of Medivation with the acquisition of AstraZenecas antibiotics for a cool US$1.5bn. With the divestment, … more ➔
